- Home
- ETON vs WLKP Comparison
ETON vs WLKP Comparison
Compare ETON & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | WLKP |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.8M | 795.5M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ETON | WLKP |
|---|---|---|
| Price | $30.29 | $23.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 343.5K | 25.8K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $79,950,000.00 | ★ $1,166,695,000.00 |
| Revenue This Year | $40.90 | $19.48 |
| Revenue Next Year | $47.23 | $5.24 |
| P/E Ratio | ★ N/A | $15.30 |
| Revenue Growth | ★ 104.94 | 2.71 |
| 52 Week Low | $13.09 | $17.75 |
| 52 Week High | $32.31 | $23.88 |
Technical Indicators
Market Signals| Indicator | ETON | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 65.85 |
| Support Level | $16.17 | $21.64 |
| Resistance Level | $32.31 | N/A |
| Average True Range (ATR) | 1.54 | 0.52 |
| MACD | 0.26 | 0.08 |
| Stochastic Oscillator | 79.33 | 88.96 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About WLKP Westlake Chemical Partners LP
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.